Tilray Brands (NASDAQ:TLRY) Insider Denise Faltischek Purchases 2,500 Shares

Tilray Brands, Inc. (NASDAQ:TLRYGet Free Report) insider Denise Faltischek purchased 2,500 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was acquired at an average cost of $4.78 per share, with a total value of $11,950.00. Following the acquisition, the insider owned 141,285 shares in the company, valued at $675,342.30. The trade was a 1.80% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

Tilray Brands Stock Performance

TLRY opened at $4.64 on Wednesday. The stock has a 50-day moving average of $4.64 and a 200 day moving average of $6.17. The company has a current ratio of 2.21, a quick ratio of 1.37 and a debt-to-equity ratio of 0.22. Tilray Brands, Inc. has a 12 month low of $3.67 and a 12 month high of $23.20. The firm has a market cap of $540.79 million, a P/E ratio of -4.30 and a beta of 1.90.

Tilray Brands (NASDAQ:TLRYGet Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.42). The company had revenue of $281.71 million for the quarter, compared to analysts’ expectations of $246.30 million. Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%. As a group, research analysts forecast that Tilray Brands, Inc. will post -0.34 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Wall Street Zen downgraded shares of Tilray Brands from a “hold” rating to a “sell” rating in a research note on Saturday. TD Securities raised shares of Tilray Brands to a “strong-buy” rating in a research report on Friday, July 31st. Weiss Ratings downgraded shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Finally, TD Cowen dropped their target price on Tilray Brands from $7.00 to $5.00 and set a “buy” rating for the company in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $11.00.

Read Our Latest Report on TLRY

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

  • Positive Sentiment: CFO Carl A. Merton purchased 10,000 shares for approximately $46,200, increasing his holdings by 7.71%. Insider buying can signal management confidence that the stock is undervalued. SEC insider ownership filing
  • Positive Sentiment: Insider Denise M. Faltischek bought 2,500 shares worth approximately $11,950, increasing her ownership by 1.80%. The additional insider purchase reinforces the positive signal from management. SEC insider ownership filing
  • Positive Sentiment: TD Securities upgraded Tilray, potentially improving sentiment toward the shares and signaling a more favorable view of the company’s outlook. Tilray Brands upgraded at TD Securities
  • Positive Sentiment: Tilray’s distribution segment delivered double-digit growth in fiscal 2026, making it the company’s strongest reported growth driver. Tilray distribution growth article
  • Neutral Sentiment: Tilray appeared on a Nasdaq Composite watchlist, increasing visibility but offering no direct change to the company’s fundamentals or earnings outlook. Why Tilray is a Nasdaq Composite watchlist stock
  • Negative Sentiment: Although Tilray reported record fiscal 2026 results, analysts remain concerned that acquisitions make it difficult to measure true organic growth. That uncertainty weakens the case for buying the stock despite headline growth. Tilray record fiscal 2026 results analysis

Institutional Trading of Tilray Brands

Several institutional investors and hedge funds have recently made changes to their positions in TLRY. Hilton Head Capital Partners LLC purchased a new stake in shares of Tilray Brands during the fourth quarter valued at $38,000. Cerity Partners LLC increased its stake in Tilray Brands by 98.5% in the 2nd quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after buying an additional 45,929 shares during the period. Marex Group plc purchased a new position in Tilray Brands in the 2nd quarter worth about $40,000. Hilton Capital Management LLC bought a new stake in Tilray Brands during the 2nd quarter valued at about $41,000. Finally, Essential Partners LLC lifted its holdings in Tilray Brands by 110,137.5% during the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock valued at $57,000 after buying an additional 8,811 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors.

Tilray Brands Company Profile

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

Read More

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.